Prudential Financial’s Foghorn Therapeutics FHTX Stock Holding History

Prudential Financial’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.3K	Buy	+12,205	New	+$67K	﹤0.01%	2294

Other funds holding FHTX

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Prudential Financial's FHTX Position: Q1 2026 in Review

Prudential Financial opened a new position in Foghorn Therapeutics (FHTX) in Q1 2026: 12,205 shares worth $58.3K. The stake represents ﹤0.01% of the portfolio and ranks #2294 among its holdings.

105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

Prudential Financial held 12,205 shares of Foghorn Therapeutics worth $58.3K as of Q1 2026.
Foghorn Therapeutics was a new Prudential Financial position in Q1 2026.
Foghorn Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2294 holding.
105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.